Cardio-TriTest vs Analytic for Hemodynamic Instability (AHI)
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 70/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Cardio-TriTest is designed for comprehensive cardiovascular disease diagnosis in primary care settings, utilizing a multi-modal device combining ECG, PCG, and MCG. In contrast, Fifth Eye's AHI System is an AI-driven software for predicting hemodynamic instability in adult in-hospital patients, leveraging continuous ECG lead II data for early warnings. While both are AI-powered cardiology tools, they address different clinical needs and patient populations.
Choose Cardio-TriTest if…
Choose Cardio-TriTest if your primary care clinic seeks a comprehensive, non-invasive diagnostic device for earlier and more thorough cardiovascular disease detection. This tool is ideal for synchronizing and visually correlating ECG, PCG, and MCG bio-signals to provide a holistic view of cardiac health in an outpatient setting.
View Cardio-TriTest →Choose Analytic for Hemodynamic Instability (AHI) if…
Choose Analytic for Hemodynamic Instability (AHI) if your hospital needs an AI-driven clinical decision support system for continuous, real-time monitoring of adult in-patients at risk of hemodynamic instability. This software excels at providing early warnings hours before traditional vital signs, enabling proactive intervention and streamlining critical care workflows.
View Analytic for Hemodynamic Instability (AHI) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cardio-TriTest | Analytic for Hemodynamic Instability (AHI) |
|---|---|---|
| Deployment | On-premise (device) | Integrates with existing hospital ECGs and can be deployed through platforms like Medical Informatics Corp.'s Sickbay™ and VitalConnect's remote patient monitoring solution. |
| FDA Status | Unknown | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cardio-TriTest | Analytic for Hemodynamic Instability (AHI) |
|---|---|---|
| Tool Name | Cardio-TriTest | Analytic for Hemodynamic Instability (AHI) |
| Company | Cardio-Phoenix Inc. | Fifth Eye |
| Description | Cardio-TriTest v6.5 by Cardio-Phoenix Inc. is an AI-powered 3-in-1 diagnostic device combining ECG, PCG, and MCG to synchronize and visually correlate heart bio-signals for earlier and more comprehensive cardiovascular disease detection in primary care. | Fifth Eye's AHI System is an FDA-cleared, AI-driven clinical decision support software that continuously monitors adult in-hospital patients for signs of hemodynamic instability, providing early warnings hours ahead of traditional vital signs. |
| Key Features | 3-in-1 diagnostic device (ECG, PCG, MCG), 12-Lead Electrocardiograph (ECG), 4 Lead Phonocardiograph (PCG), 4 Lead Mechanocardiograph (MCG), Synchronized bio-signal acquisition, Visual correlation of heart bio-signals, AI-powered analysis for heart disease detection, Non-invasive test procedure | Real-time clinical analytics based on physiologic waveforms, Predicts hemodynamic instability earlier than vital signs (up to 26 hours for AHI-PI), Uses continuous ECG lead II data for analysis, AI-driven and machine learning-based technology, Clinical decision support software for healthcare professionals, Easy-to-interpret visual indicators (red, yellow, green), Reduces nurse surveillance burden and streamlines workflow, Integrates with existing in-hospital monitoring platforms (e.g., Sickbay, VitalConnect) |
| Categories | Cardiology AI | Cardiology AI, Triage & ER/ICU AI |
| Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology, Critical Care, Emergency Medicine |
Videos
Demos, reviews, and walkthroughs featuring Cardio-TriTest and Analytic for Hemodynamic Instability (AHI).
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
Cardio-TriTest is a device-based diagnostic tool designed for primary care settings, combining ECG, PCG, and MCG for earlier and more comprehensive cardiovascular disease detection. AHI, as a software, integrates with existing in-hospital monitoring platforms to provide continuous, real-time clinical decision support for adult patients at risk of hemodynamic instability, aiming to streamline surveillance and reduce nurse burden.
Cardio-TriTest is a device-based system, and the specifics of its EHR integration for data export are not detailed in the provided information. AHI is a Software as a Medical Device (SaMD) that integrates with existing in-hospital monitoring platforms, which can serve as conduits for data flow into EHRs, potentially streamlining documentation and providing real-time data sync.
Cardio-TriTest aims for earlier and more comprehensive cardiovascular disease detection by synchronizing and visually correlating ECG, PCG, and MCG bio-signals. AHI specifically claims to predict hemodynamic instability hours, and up to 26 hours for AHI-PI, earlier than traditional vital signs, demonstrating superior detection compared to traditional vital signs in identifying patient deterioration.
Cardio-TriTest is suited for Cardiology, Family Medicine, and Internal Medicine, focusing on general cardiovascular disease detection in primary care settings for adults. AHI is designed for Cardiology, Critical Care, and Emergency Medicine, specifically for continuous monitoring of adult in-hospital patients (18 years or older) at risk of hemodynamic instability.
Cardio-TriTest involves operating a 3-in-1 diagnostic device and interpreting visually correlated heart bio-signals, which may require training on device usage and pattern recognition. AHI provides easy-to-interpret visual indicators (red, yellow, green) based on continuous ECG data, suggesting a potentially lower learning curve for interpreting its clinical decision support.
Cardio-TriTest's value stems from enabling earlier and more comprehensive cardiovascular disease detection, potentially leading to earlier interventions. AHI offers immediate value by providing early warnings of hemodynamic instability up to 26 hours in advance, allowing for proactive patient care and potentially reducing nurse surveillance burden and improving resource allocation.
More Comparisons
More matchups featuring Cardio-TriTest or Analytic for Hemodynamic Instability (AHI)
- Analytic for Hemodynamic Instability (AHI) vs Sleepiz One+
- Cardio-TriTest vs SOMATOM X.ceed
- Analytic for Hemodynamic Instability (AHI) vs EchoNext
- Cardio-TriTest vs EchoNext
- Analytic for Hemodynamic Instability (AHI) vs Irregular Rhythm Notification Feature (IRNF)
- Analytic for Hemodynamic Instability (AHI) vs Study Watch with Irregular Pulse Monitor